BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37183868)

  • 1. Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk.
    Jiao J; Yu Y; Wei S; Tian X; Yang X; Feng S; Li Y; Sun S; Zhang P; Bai M
    Ren Fail; 2023 Dec; 45(1):2210691. PubMed ID: 37183868
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of regional citrate anticoagulation in membrane therapeutic plasma exchange.
    Yuan F; Li Z; Li X; Liu H
    Int Urol Nephrol; 2020 Dec; 52(12):2379-2384. PubMed ID: 32740788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
    Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
    J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure.
    Hu J; Wang C; Bai K; Liu C
    Front Pediatr; 2023; 11():1206999. PubMed ID: 37928357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption Plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study.
    Ma Y; Chen F; Xu Y; Wang M; Zhou T; Lu J; Feng P; Wang Y; Bai L; Tang H
    Blood Purif; 2019; 48(3):223-232. PubMed ID: 31216551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis: a prospective multicenter randomized controlled trial.
    Tang X; Chen D; Zhang L; Fu P; Chen Y; Xiao Z; Xiao X; Peng W; Cheng L; Zhang Y; Li H; Li K; Gou B; Wu X; Yu Q; Jian L; Zhu Z; Wen Y; Liu C; Xue H; Zhang H; He X; Yan B; Zhong L; Huang B; Mao M
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):931-942. PubMed ID: 36379612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate anticoagulation in plasma exchange followed by continuous renal replacement therapy in critically ill children.
    Xinping Z; Jie H; Zhenya Y; Desheng Z; Xiong Z
    Int J Artif Organs; 2024 Feb; 47(2):85-95. PubMed ID: 38229209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study.
    Li L; Bai M; Zhang W; Zhao L; Yu Y; Sun S
    Int J Artif Organs; 2022 Apr; 45(4):343-350. PubMed ID: 33784842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation vs systemic heparin anticoagulation for double-filtration plasmapheresis.
    Teh SP; Ho QY; Kee YST; Thangaraju S; Tan RY; Teo SH; Tan HK; Tan CS; Choong HLL; Ng LC; Abdul Rahman M; Lim AEL; Kaushik M
    J Clin Apher; 2023 Feb; 38(1):16-23. PubMed ID: 36197100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.
    Lin T; Song L; Huang R; Huang Y; Tang S; Lin Q; Zhang Y; Wu X; Liang H; Wu Y; Chen Y; Liang H; Ma J; Feng Z; Li Z; Xu L; Fu X; Ye Z; Liu S; Liang X
    BMC Nephrol; 2019 Dec; 20(1):472. PubMed ID: 31856749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis comparing complication rates of centrifuge vs membrane-based therapeutic plasma exchange in the pediatric population.
    Webb TN; Bell J; Griffin R; Dill L; Gurosky C; Askenazi D
    J Clin Apher; 2022 Jun; 37(3):263-272. PubMed ID: 35137962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    Yu Y; Bai M; Ma F; Zhang W; Li Y; Zhao L; Li L; Zhou M; Li L; Sun S
    PLoS One; 2020; 15(5):e0232516. PubMed ID: 32369523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study.
    Ho QY; Teh SP; Thangaraju S; Teo SH; Tan HK; Abdul Rahman MB; Ng LC; Lim AEL; Choong LHL; Kee T; Kaushik M;
    Blood Purif; 2022; 51(4):376-382. PubMed ID: 34198288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.